0001104659-25-009813 Sample Contracts

2,700,000 Shares of Common Stock Nuvectis Pharma, Inc. UNDERWRITING AGREEMENT

Underwriting Agreement • February 6th, 2025 • Nuvectis Pharma, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Underwriting Agreement
• Filed
  February 6th, 2025
• Company
  Nuvectis Pharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Nuvectis Pharma, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Lucid Capital Markets, LLC (the “Underwriter”) an aggregate of 2,700,000 authorized but unissued shares (the “Firm Shares”) of the Company’s common stock, $0.00001 par value per share (the “Common Stock”). The Company also proposes to sell to the Underwriter, at the option of the Underwriter, up to an additional 405,000 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares.”